4 transcripts
LCTX
Earnings call transcript
AMEX
2024 Q2
8 Aug 24
of the eye. The second is overall safety. And the third is improvement in retinal structure, which, by the way, is an outcome measure that wasn't even
LCTX
Earnings call transcript
AMEX
2024 Q1
9 May 24
on a cohort of 10 patients rather than the large number of patients used to determine findings of safety and efficacy for marketing authorization
LCTX
Earnings call transcript
AMEX
2023 Q4
7 Mar 24
the clinical safety and performance of a new delivery device called my PSD.
As a reminder, the pioneering work on this program was originally
LCTX
Earnings call transcript
AMEX
2023 Q2
10 Aug 23
developments in the dry AMD space and how I see those events positively affecting our lead program.
As you no doubt are aware, there have been safety
- Prev
- 1
- Next